Web Stats Provided By Google Analytics

Tuesday, November 5, 2013

AASLD 2013: Sofosbuvir + Ribavirin Gives Sustained Response in 76% of ...

An interferon-free regimen of sofosbuvir plus ribavirin taken for 24 weeks cured three-quarters of previously untreated HIV positive people coinfected with hepatitis C virus genotype 1, while 12 weeks of treatment cured 88% and 67% of those with genotypes 2 or 3, according to findings from the Phase 3 PHOTON-1 study presented this week at the 64th ... (more)

http://www.hivandhepatitis.com/hiv-hep-coinfection/hiv-hcv-coinfection/4396-aasld-2013-sofosbuvir-ribavirin-gives-sustained-response-in-76-of-gt-1-hivhcv-coinfected-patients

No comments:

Post a Comment